-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
ACSS2-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2711039-08-4.gif)
| Category | Respiratory syncytial Virus (RSV) |
| CAS | 2711039-08-4 |
| Description | ACSS2-IN-1 is a potent ACSS2 inhibitor used in the treatment of cancer. |
Product Information
| Synonyms | ACSS2-IN-1|CHEMBL4846168|BDBM50574370|HY-145392|CS-0372824 |
| IUPAC Name | 6-chloro-3-ethyl-N-(1-ethyl-1,2,4-triazol-3-yl)-2-[hydroxy(diphenyl)methyl]pyrazolo[1,5-a]pyridine-5-carboxamide |
| Molecular Weight | 500.98 |
| Molecular Formula | C27H25ClN6O2 |
| Canonical SMILES | CCC1=C2C=C(C(=CN2N=C1C(C3=CC=CC=C3)(C4=CC=CC=C4)O)Cl)C(=O)NC5=NN(C=N5)CC |
| InChI | InChI=1S/C27H25ClN6O2/c1-3-20-23-15-21(25(35)30-26-29-17-33(4-2)32-26)22(28)16-34(23)31-24(20)27(36,18-11-7-5-8-12-18)19-13-9-6-10-14-19/h5-17,36H,3-4H2,1-2H3,(H,30,32,35) |
| InChIKey | WLUNFHGEBAZYCQ-UHFFFAOYSA-N |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 728 |
| Exact Mass | 500.1727518 |
| Target | RSV |
| XLogP3-AA | 4.4 |
